BDBM260259 US9522914, B-12

SMILES CC(C)NC(=O)Cn1nc(nc1-c1ccc(F)c(Cl)c1)-c1ccc(CCN2CCOCC2)cn1

InChI Key InChIKey=WQDUMLVTWXMYAX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 260259   

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260259(US9522914, B-12)
Affinity DataIC50: 6.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2017
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260259(US9522914, B-12)
Affinity DataIC50: 6.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent